ClinConnect ClinConnect Logo
Search / Trial NCT06829615

Contactless Measurement of Heart Rate, Heart Rate Variability, Breathing Rate and Blood Pressure Using Remote Photoplethysmography

Launched by SHEN.AI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ ODDZIAŁ W POLSCE · Feb 14, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to measure important health signals like heart rate, breathing rate, and blood pressure using a special software called Shen.AI. The goal is to see how accurately this technology can monitor these vital signs without needing to touch the patient—this is called contactless measurement. This could be useful for people who need regular health checks but prefer a more convenient method.

To participate in the study, you need to be at least 18 years old, be able to read and write in Polish or English, and comfortably use a mobile device or laptop. You also need to be able to understand the study instructions and give your consent to join. However, there are some health conditions that would exclude you from participating, such as certain heart or lung problems, pregnancy, or extensive facial injuries. If you qualify, you can expect to complete some simple tasks using the technology while following the guidance of the study team. This trial is not yet recruiting participants, so keep an eye out for updates if you're interested!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Ability to read and write in Polish or English
  • Ability to operate a mobile device and a laptop without requiring glasses
  • Ability to understand the study procedure
  • Ability to communicate and follow instructions from the study personnel
  • Provision of written informed consent for participation in the study and for the processing of personal data by the research team and the study sponsor
  • Blood pressure values in accordance with the distribution of the study group
  • Exclusion Criteria:
  • Pregnancy
  • Age below 18 years
  • Failure to provide the required information in the participant's informational questionnaire
  • Non-compliance with the study procedure or instructions from the study personnel
  • Extensive facial skin damage (e.g., abrasions, wounds, burns)
  • A disease process affecting a significant portion of the face
  • Extensive facial dressing
  • Extensive facial tattoos or facial painting
  • Significant facial deformity (e.g., tumor)
  • Inability to maintain a stable head position during measurement
  • Persistent cough preventing stillness during measurement
  • Respiratory dysfunction such as dyspnea, irregular or shallow breathing
  • Diagnosed arrhythmia (except for sinus bradycardia or sinus tachycardia)
  • Moderate or severe anemia
  • Diagnosed conditions such as left ventricular systolic dysfunction, aortic valve stenosis, or other cardiac or circulatory diseases leading to low stroke volume, low pulse amplitude, or pulsus paradoxus
  • Implanted cardiac pacemaker
  • Blood pressure difference between arms exceeding 15 mmHg for systolic pressure or 10 mmHg for diastolic pressure
  • Inability to determine blood pressure in both arms

About Shen.Ai Spółka Z Ograniczoną Odpowiedzialnością Oddział W Polsce

Shen.ai spółka z ograniczoną odpowiedzialnością oddział w Polsce is a forward-thinking clinical trial sponsor dedicated to advancing healthcare through innovative research and development in artificial intelligence-driven solutions. With a strong commitment to enhancing patient outcomes, the company leverages cutting-edge technology to streamline clinical processes and improve data accuracy. Operating within regulatory frameworks, Shen.ai collaborates with healthcare professionals, institutions, and stakeholders to facilitate groundbreaking studies that contribute to the future of medicine in Poland and beyond.

Locations

Wrocław, Dolnośląskie, Poland

Wrocław, Dolnośląskie, Poland

Wrocław, , Poland

Wrocław, , Poland

Patients applied

0 patients applied

Trial Officials

Justyna Chojdak-Łukasiewicz, MD, PhD

Principal Investigator

Wroclaw Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported